Could it be possible to diagnose Parkinson’s disease with the help of a simple retinal exam? The idea should be seriously considered, according to a study published in the May issue of Neurobiology of Disease by researchers from Université Laval who discovered that the retina of people with Parkinson’s disease responds differently to light stimuli than that of healthy people.
In Nature Communications, the laboratory of Professor Jan Terje Andersen and collaborators report on a novel vaccine technology platform, in which the subunit antigen is genetically fused to albumin.
A discovery by scientists at Henry Ford Health + Michigan State University Health Sciences could pave the way for new breakthroughs in detecting and treating the disease. Their findings were recently published in Nature Communications.
During the early teen years, many new strains of C. acnes colonize the skin on our faces. This could be an optimal time for probiotic treatment.
Edwards Lifesciences (NYSE: EW) announced today that it received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.
Intuitive (NASDAQ: ISRG)+
announced today that it received FDA clearance for a new indication for its da Vinci single port (SP) surgical robot.
Element Science announced today that it received FDA pre-market approval for its Jewel Patch wearable cardioverter defibrillator (WCD).
Neuralink said today on social media that it received FDA breakthrough device designation for treating individuals with severe speech impairment.
With the increasing demand for underwater and implantable medical electronics, a stable and continuous power supply is essential. However, conventional wireless charging methods (such as electromagnetic induction and radio frequency-based charging) used in smartphones and wireless earphones suffer from short transmission distances, low energy transfer efficiency in biological tissues, and electromagnetic interference.
Teleflex (NYSE: TFX) announced today that it received FDA 510(k) clearance for expanded indications of its QuikClot Control+ hemostatic device.